Glass House Brands (GLAS) Goodwill & Intangibles (2020 - 2026)
Glass House Brands' (GLAS) quarterly Goodwill & Intangibles came in at $11.6 million in Q1 2026, down 4.08% year-on-year from $12.1 million in Q1 2025, and little changed on a QoQ basis from $11.6 million in Q4 2025.
Glass House Brands (GLAS) Goodwill & Intangibles (2020 - 2026) Analysis & Trends
Glass House Brands (GLAS) has 7 years of Goodwill & Intangibles data on file, last reported at $11.6 million in Q1 2026.
- On a quarterly basis, Goodwill & Intangibles fell 4.08% year-over-year to $11.6 million in Q1 2026; TTM through Mar 2026 was $11.6 million, a 4.08% decrease from a year earlier, with the FY2025 full-year figure at $11.6 million, down 18.47% from the prior year.
- Goodwill & Intangibles for Q1 2026 stood at $11.6 million, roughly flat from $11.6 million in the prior quarter.
- Over the last five years, Goodwill & Intangibles for GLAS reached as high as $70.3 million in Q4 2022 and fell as low as $10.5 million in Q1 2022.
- Historically, Goodwill & Intangibles has averaged $28.7 million across 5 years, with a median of $20.9 million in 2024.
- On a YoY basis, Goodwill & Intangibles climbed as much as 1178.42% in 2022 and fell as far as 94.22% in 2022.
- Year by year, Goodwill & Intangibles stood at $70.3 million in 2022, then slumped by 69.83% to $21.2 million in 2023, then slumped by 33.06% to $14.2 million in 2024, then decreased by 18.47% to $11.6 million in 2025, then increased by 0.42% to $11.6 million in 2026.
- Per Business Quant data, the three most recent Goodwill & Intangibles figures were $11.6 million in Q1 2026, $11.6 million in Q4 2025, and $11.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | Glass House Brands | 873.84 Mn | 845.91 Mn | 10.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.63 Mn |
| Dec 31, 2025 | 11.58 Mn |
| Sep 30, 2025 | 11.76 Mn |
| Jun 30, 2025 | 11.94 Mn |
| Mar 31, 2025 | 12.12 Mn |
| Dec 31, 2024 | 14.20 Mn |
| Sep 30, 2024 | 14.38 Mn |
| Jun 30, 2024 | 20.87 Mn |
| Mar 31, 2024 | 21.01 Mn |
| Dec 31, 2023 | 21.21 Mn |
| Sep 30, 2023 | 52.30 Mn |
| Jun 30, 2023 | 46.80 Mn |
| Mar 31, 2023 | 53.63 Mn |
| Dec 31, 2022 | 70.32 Mn |
| Sep 30, 2022 | 68.55 Mn |
| Jun 30, 2022 | 34.98 Mn |
| Mar 31, 2022 | 10.51 Mn |
| Dec 31, 2021 | 5.50 Mn |
| Sep 30, 2021 | 9.84 Mn |
| Mar 31, 2021 | 181.84 Mn |